Who owns FOGHORN THERAPEUTICS INC?
- Ticker: FHTX
- CUSIP Number: 344174107
Tip: Access positions for across all investors
Analyze quarterly positions in Foghorn Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Foghorn Therapeutics stock
Who bought or sold FOGHORN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Flagship Ventures Management | 13M | $85M | 0% | Mar 2024 |
|
| FMR | 2.7M | $18M | -7% | Mar 2024 |
|
| Raymond James & Associates | 2.2M | $15M | 8% | Mar 2024 |
|
| Euclidean Capital | 1.6M | $11M | 0% | Mar 2024 |
|
| BlackRock | 1.3M | $8.8M | -5% | Mar 2024 |
|
| Vanguard Group | 1.1M | $7.4M | 8% | Mar 2024 |
|
| Artal Group | 721k | $4.8M | 0% | Mar 2024 |
|
| Alphabet | 501k | $3.4M | 0% | Mar 2024 |
|
| Geode Capital Management | 448k | $3.0M | 5% | Mar 2024 |
|
| Point72 Asset Management | 437k | $2.9M | -19% | Mar 2024 |
|
| Jacobs Levy Equity Management | 216k | $1.5M | 101% | Mar 2024 |
|
| Northern Trust | 195k | $1.3M | -3% | Mar 2024 |
|
| Sio Capital Management | 122k | $816k | 100% | Mar 2024 |
|
| Colony | 108k | $632k | 100% | Mar 2024 |
|
| Rockwood Wealth Management | 107k | $720k | -50% | Mar 2024 |
|
| PanAgora Asset Management | 100k | $673k | 3% | Mar 2024 |
|
| Morgan Stanley | 75k | $503k | 4% | Mar 2024 |
|
| Millennium Management | 62k | $416k | 100% | Mar 2024 |
|
| Bank of New York Mellon | 61k | $408k | 6% | Mar 2024 |
|
| Charles Schwab Investment Management | 55k | $372k | 0% | Mar 2024 |
|
| Nuveen Asset Management | 54k | $362k | 1% | Mar 2024 |
|
| Exchange Traded Concepts | 47k | $316k | 119% | Mar 2024 |
|
| Baker Bros. Advisors | 45k | $302k | 0% | Mar 2024 |
|
| Acadian Asset Management | 42k | $283k | 100% | Mar 2024 |
|
| Marshall Wace | 37k | $245k | 100% | Mar 2024 |
|
| Citadel Advisors | 33k | $221k | 100% | Mar 2024 |
|
| Alta Wealth Advisors | 30k | $202k | 0% | Mar 2024 |
|
| Rhumbline Advisers | 27k | $179k | 3% | Mar 2024 |
|
| CornerCap Investment Counsel | 26k | $173k | 0% | Mar 2024 |
|
| GSA Capital Partners | 22k | $147k | -47% | Mar 2024 |
|
| UBS Group | 20k | $137k | -13% | Mar 2024 |
|
| Barclays | 19k | $129k | -42% | Mar 2024 |
|
| Susquehanna International | 16k | $108k | -49% | Mar 2024 |
|
| Jpmorgan Chase & Co | 14k | $94k | 7% | Mar 2024 |
|
| Hsbc Holdings | 14k | $91k | 0% | Dec 2023 |
|
| XTX Topco | 13k | $90k | 100% | Mar 2024 |
|
| Bank of America Corporation | 13k | $85k | -56% | Mar 2024 |
|
| Florida State Board of Administration | 13k | $77k | 100% | Mar 2024 |
|
| Goldman Sachs Group | 11k | $77k | -20% | Mar 2024 |
|
| Fiduciary Trust Company | 11k | $70k | 0% | Dec 2023 |
|
| American International | 10k | $65k | 0% | Dec 2023 |
|
| Alliancebernstein | 10k | $65k | -7% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 9.6k | $64k | -4% | Mar 2024 |
|
| Lazard Asset Management | 9.0k | $57k | 100% | Dec 2023 |
|
| Royal Bank of Canada | 8.4k | $61k | 30% | Mar 2024 |
|
| Wells Fargo & Company | 6.1k | $41k | 15% | Mar 2024 |
|
| NISA Investment Advisors | 5.0k | $34k | 0% | Mar 2024 |
|
| Citigroup | 3.4k | $23k | 15% | Mar 2024 |
|
| New York State Common Retirement Fund | 2.4k | $16k | 29% | Mar 2024 |
|
| Simplex Trading | 2.1k | $14k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 2.0k | $14k | -54% | Mar 2024 |
|
| Legal & General Group | 2.0k | $13k | 0% | Mar 2024 |
|
| Summit Investment Advisors | 1.5k | $10k | 0% | Mar 2024 |
|
| Sunbelt Securities | 1.5k | $10k | 0% | Mar 2024 |
|
| Washington Trust Company | 1.5k | $10k | 0% | Mar 2024 |
|
| Amalgamated Bank | 681.00 | $5.0k | -76% | Mar 2024 |
|
| Capital Analysts | 547.00 | $4.0k | 0% | Mar 2024 |
|
| Tower Research Capital | 394.00 | $2.6k | -92% | Mar 2024 |
|
| VisionPoint Advisory Group | 210.00 | $1.4k | 0% | Mar 2024 |
|
| Group One Trading | 151.00 | $1.0k | -75% | Mar 2024 |
|
| TFC Financial Management | 123.00 | $825.994200 | 0% | Mar 2024 |
|
| Cutler | 100.00 | $0 | 100% | Mar 2024 |
|
| Capital Advisors | 7.00 | $0 | 100% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 3.00 | $20.000100 | 100% | Mar 2024 |
|
| Zurcher Kantonalbank | 2.00 | $13.000000 | 0% | Mar 2024 |
|
| CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Foghorn Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| GW & Wade | Sep 2023 | 108k | $539k |
| Jane Street | Dec 2023 | 13k | $83k |
| MetLife Investment Advisors | Sep 2023 | 11k | $57k |
| Metropolitan Life Insurance Company | Sep 2023 | 1.3k | $6.5k |
| Russell Investments | Dec 2023 | 100.00 | $645.000000 |